| The influence of prior industry experience and multidisciplinary teamwork on student design learning in a capstone design course K Gruenther, R Bailey, J Wilson, C Plucker, H Hashmi Design Studies 30 (6), 721-736, 2009 | 55 | 2009 |
| Integrated network analyses for functional genomic studies in cancer JL Wilson, MT Hemann, E Fraenkel, DA Lauffenburger Seminars in cancer biology 23 (4), 213-218, 2013 | 20 | 2013 |
| Biomarkers: Delivering on the expectation of molecularly driven, quantitative health JL Wilson, RB Altman Experimental Biology and Medicine 243 (3), 313-322, 2018 | 18 | 2018 |
| PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development JL Wilson, R Racz, T Liu, O Adeniyi, J Sun, A Ramamoorthy, ... PLoS computational biology 14 (12), e1006614, 2018 | 15 | 2018 |
| Harnessing systems biology approaches to engineer functional microvascular networks LS Sefcik, JL Wilson, JA Papin, EA Botchwey Tissue Engineering Part B: Reviews 16 (3), 361-370, 2010 | 12 | 2010 |
| From random to predictive: a context-specific interaction framework improves selection of drug protein–protein interactions for unknown drug pathways JL Wilson, A Gravina, K Grimes Integrative Biology 14 (1), 13-24, 2022 | 7 | 2022 |
| Pathway-based network modeling finds hidden genes in shRNA screen for regulators of acute lymphoblastic leukemia JL Wilson, S Dalin, S Gosline, M Hemann, E Fraenkel, DA Lauffenburger Integrative Biology 8 (7), 761-774, 2016 | 7 | 2016 |
| Scientific considerations for global drug development JL Wilson, KWK Cheung, L Lin, EAE Green, AI Porrás, L Zou, D Mukanga, ... Science translational medicine 12 (554), eaax2550, 2020 | 6 | 2020 |
| PathFXweb: a web application for identifying drug safety and efficacy phenotypes JL Wilson, M Wong, A Chalke, N Stepanov, D Petkovic, RB Altman Bioinformatics 35 (21), 4504-4506, 2019 | 6 | 2019 |
| An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias JL Wilson, D Lu, N Corr, A Fullerton, J Lu PLOS Computational Biology 16 (7), e1007620, 2020 | 5 | 2020 |
| Model utility of a deep learning-based segmentation is not Dice coefficient dependent: A case study in volumetric brain blood vessel segmentation M Alidoost, V Ghodrati, A Ahmadian, A Shafiee, CH Hassani, A Bedayat, ... Intelligence-Based Medicine, 100092, 2023 | 4 | 2023 |
| Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain SheddingNovel Regulators of TGFα Shedding JL Wilson, E Kefaloyianni, L Stopfer, C Harrison, VS Sabbisetti, ... Molecular Cancer Research 16 (1), 147-161, 2018 | 4 | 2018 |
| A network paradigm predicts drug synergistic effects using downstream protein–protein interactions JL Wilson, E Steinberg, R Racz, RB Altman, N Shah, K Grimes CPT: Pharmacometrics & Systems Pharmacology, 2022 | 3 | 2022 |
| Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks A Gravina, JL Wilson, D Bacciu, KJ Grimes, C Priami PLOS Computational Biology 18 (5), e1009531, 2022 | 3 | 2022 |
| Three questions to address rigour and reproducibility concerns in your grant proposal. JL Wilson, CM Botham Nature 596 (7873), 609-610, 2021 | 3 | 2021 |
| PhenClust, a standalone tool for identifying trends within sets of biological phenotypes using semantic similarity and the Unified Medical Language System metathesaurus JL Wilson, M Wong, N Stepanov, D Petkovic, R Altman JAMIA open 4 (3), ooab079, 2021 | 3 | 2021 |
| An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials O Adeniyi, A Ramamoorthy, R Schuck, J Sun, J Wilson, I Zineh, ... Clinical Pharmacology & Therapeutics 106 (4), 841-846, 2019 | 3 | 2019 |
| Evaluating Angiogenic Potential of Small Molecules Using Genetic Network Approaches A Das, P Merrill, J Wilson, T Turner, M Paige, S Capitosti, M Brown, ... Regenerative engineering and translational medicine 5 (1), 30-41, 2019 | 3 | 2019 |
| A scientist engineer’s contribution to therapeutic discovery and development JL Wilson Experimental Biology and Medicine 243 (14), 1125-1132, 2018 | 1 | 2018 |
| Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease J Wilson, E Bowen, P DiGiacomo, H Fraser, K Guttenplan, B Smith, ... | | 2022 |
